400 related articles for article (PubMed ID: 37495962)
1. Treatment and outcome of IgA nephropathy in children from one single center experience.
Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
3. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
[TBL] [Abstract][Full Text] [Related]
4. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
[TBL] [Abstract][Full Text] [Related]
5. Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children.
Zhao JL; Wang JJ; Huang GP; Feng CY
Medicine (Baltimore); 2021 May; 100(21):e26050. PubMed ID: 34032732
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
[TBL] [Abstract][Full Text] [Related]
7. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive agents for treating IgA nephropathy.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
[TBL] [Abstract][Full Text] [Related]
11. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
Chen KJ; Cheng CH; Wu MJ; Chen CH; Shu KH
J Chin Med Assoc; 2003 May; 66(5):263-70. PubMed ID: 12908567
[TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy with minimal change disease.
Herlitz LC; Bomback AS; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1033-9. PubMed ID: 24721885
[TBL] [Abstract][Full Text] [Related]
13. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
Hwang YC; Lee TW; Kim MJ; Yang MH; Ihm CG
Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896
[TBL] [Abstract][Full Text] [Related]
15. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
16. Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis.
Beck N; Walz G; Schneider J
Kidney360; 2022 Mar; 3(3):506-515. PubMed ID: 35582170
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study.
Chen S; Yin Q; Ren S; Zhong X; Wang W; Li G; Wang L
Sci Rep; 2018 Sep; 8(1):13662. PubMed ID: 30209279
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA; Hennigar RA
Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
[TBL] [Abstract][Full Text] [Related]
19. Therapy of IgA nephropathy with mycophenolate mofetil--report of 3 cases.
Bergner R; Hoffmann M; Brass H; Uppenkamp M
Clin Nephrol; 2004 Mar; 61(3):207-12. PubMed ID: 15077872
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
